Who invested in Avexegen Therapeutics?
Avexegen Therapeutics's investors include National Institutes of Health, Small Business Innovation Research and Mission BioCapital.
Funding summaryUpdated 26 Oct 2026
$2.9Mraised across 1 round since 2021, from 1 source
Source recorded
Avexegen Therapeutics's investors include National Institutes of Health, Small Business Innovation Research and Mission BioCapital.
Avexegen Therapeutics has raised $2.9M across 1 round since 2021.
Avexegen Therapeutics's most recent round was a Grant of $2.9M in Feb 2021.
Its most recent round, $2.9M in Feb 2021, is also its largest on record.
Avexegen Therapeutics's first round on record, in Feb 2021, was backed by National Institutes of Health, Small Business Innovation Research and Mission BioCapital.
Avexegen Therapeutics's latest named round is a Grant, in Feb 2021.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.